Sculptor Capital’s Nu Skin NUS Stock Holding History

Sculptor Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,200	Closed	-$344K	–	384
2016 Q4	$344K	Hold	7,200	–	–	﹤0.01%	285
2016 Q3	$466K	Hold	7,200	–	–	﹤0.01%	262
2016 Q2	$333K	Buy	+7,200	New	+$290K	﹤0.01%	295

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Sculptor Capital's NUS Position: Q1 2017 in Review

Sculptor Capital sold out of Nu Skin (NUS) in Q1 2017, closing a stake of 7,200 shares — an estimated $344K sold.

Sculptor Capital first reported a position in NUS in Q3 2013 and held it in 7 quarters. The position peaked at $151M in Q4 2013. 255 funds tracked by Wall St. Rank hold NUS as of Q1 2017.

Sculptor Capital reported no remaining Nu Skin position as of Q1 2017 after selling out during the quarter.
Sculptor Capital sold 7,200 Nu Skin shares in Q1 2017, an estimated $344K.
Sculptor Capital first reported a position in Nu Skin in Q3 2013 and held it in 7 quarters.
Sculptor Capital's Nu Skin position peaked at $151M in Q4 2013.
255 funds tracked by Wall St. Rank held Nu Skin as of Q1 2017.

Based on Sculptor Capital's 13F filing for Q1 2017, filed 12 May 2017.